CompletedPhase 2NCT06413537

Study of SPG601 in Adult Men With Fragile X Syndrome

Studying Fragile X syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Spinogenix
Principal Investigator
Craig Erickson, MD
Children's Hospital Medical Center, Cincinnati
Intervention
SPG601(drug)
Enrollment
10 enrolled
Eligibility
18-45 years · MALE
Timeline
20242024

Study locations (1)

Collaborators

Avance Clinical Pty Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06413537 on ClinicalTrials.gov

Other trials for Fragile X syndrome

Additional recruiting or active studies for the same condition.

See all trials for Fragile X syndrome

← Back to all trials